Skip to main content
Clinical Trials/IRCT20160307026950N30
IRCT20160307026950N30
Recruiting
Phase 2

Comparison of the effect of two different doses of Labetalol on the rate of bleeding in lumbar spine fusion surgeries

Esfahan University of Medical Sciences0 sites64 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
64
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients 18 to 50 years
  • Candidate for lumbar spine fusion surgery
  • ASA Class I and II Anesthesia

Exclusion Criteria

  • History of any allergy to Labetalol
  • History of heart block
  • History of lung diseases such as asthma

Outcomes

Primary Outcomes

Not specified

Similar Trials